Q2 2018 Holdings
Filed 2018-08-07 | 7 holdings | $522.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Evelo Biosciences Inc | COM | 299734103 | $215.2K | 18,233,403 | 41.2% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $136.0K | 8,918,749 | 26.1% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $109.1K | 12,682,876 | 20.9% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $32.7K | 3,204,437 | 6.3% |
| Quanterix Corp(QTRX) | COM | 74766Q101 | $29.2K | 2,030,495 | 5.6% |